Assessments of tight junction proteins occludin, claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood-brain barrier: Cellular responses to neurotoxicants malathion and lead acetate

被引:64
作者
Balbuena, Pergentino [1 ]
Li, Wen [1 ]
Ehrich, Marion [1 ]
机构
[1] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA
关键词
BBB; Tight junctions; Malathion; Lead acetate; Endothelial cells; LONG-TERM POTENTIATION; IN-VITRO; EXPOSURE INCREASES; ZO-1; CALCIUM; EXPRESSION; MATRIX-METALLOPROTEINASE-9; PERMEABILITY; ACTIVATION; HYPOXIA;
D O I
10.1016/j.neuro.2010.10.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The blood-brain barrier (BBB) is essential for central nervous system (CNS) normal function. It is formed by endothelial cells with special characteristics, which confer the BBB with low permeability and high transendothelial electrical resistance (TEER). We previously demonstrated that malathion and lead, two neurotoxicants widely present in the environment, decrease TEER and increase permeability in in vitro models of the BBB. In this study we assessed tight junction disruption at the protein and gene expression levels using a rat brain microvascular endothelial cell line (RBE4) exposed to lead acetate at 10(-5) M and 10(-6) M. malathion at 10(-5) M, malaoxon at 10(-6) M, and their combinations. Cells were incubated with treatments for 2 h, 4 h, 8 h, 16 h, and 24 h periods. Immunoblotting assessments demonstrated that protein levels of tight junction proteins occludin and claudin 5, and scaffold proteins ZO1 and ZO2 were decreased after treatments. Gene expression determinations did not correlate with the decreases in protein, indicating that the effects on these proteins were post-translational. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 57 条
[1]   Astrocyte-endothelial interactions at the blood-brain barrier [J].
Abbott, NJ ;
Rönnbäck, L ;
Hansson, E .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) :41-53
[2]   Astrocyte-endothelial interactions and blood-brain barrier permeability [J].
Abbott, NJ .
JOURNAL OF ANATOMY, 2002, 200 (06) :629-638
[3]   Organophosphorus ester-induced chronic neurotoxicity [J].
Abou-Donia, MB .
ARCHIVES OF ENVIRONMENTAL HEALTH, 2003, 58 (08) :484-497
[4]   Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery [J].
Alavijeh M.S. ;
Chishty M. ;
Qaiser M.Z. ;
Palmer A.M. .
NeuroRX, 2005, 2 (4) :554-571
[5]   Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues [J].
AndoAkatsuka, Y ;
Saitou, M ;
Hirase, T ;
Kishi, M ;
Sakakibara, A ;
Itoh, M ;
Yonemura, S ;
Furuse, M ;
Tsukita, S .
JOURNAL OF CELL BIOLOGY, 1996, 133 (01) :43-47
[6]   Comparison of Two Blood-Brain Barrier In Vitro Systems: Cytotoxicity and Transfer Assessments of Malathion/Oxon and Lead Acetate [J].
Balbuena, Pergentino ;
Li, Wen ;
Magnin-Bissel, Geraldine ;
Meldrum, J. Blair ;
Ehrich, Marion .
TOXICOLOGICAL SCIENCES, 2010, 114 (02) :260-271
[7]   2 CLASSES OF TIGHT JUNCTIONS ARE REVEALED BY ZO-1 ISOFORMS [J].
BALDA, MS ;
ANDERSON, JM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (04) :C918-C923
[8]  
Balda MS, 1998, J CELL SCI, V111, P541
[9]   The blood-brain barrier: an overview - Structure, regulation, and clinical implications [J].
Ballabh, P ;
Braun, A ;
Nedergaard, M .
NEUROBIOLOGY OF DISEASE, 2004, 16 (01) :1-13
[10]   Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations [J].
Barbosa, Fernando, Jr. ;
Gerlach, Raquel E. ;
Tanus-Santos, Jose E. .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (06) :559-564